Arena Pharmaceuticals Inc. (ARNA) reported a first quarter loss of $0.09 per share after the bell Thursday, compared to the loss of $0.18 per share a year ago. The consensus estimate was for a profit of $0.11. The stock is now down 0.89 on 514K shares.
Arena Pharmaceuticals traded in a range for the majority of Thursday's session and closed up by 0.17 at $8.40. The stock finished near the middle of a 3-month range.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.